PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS)-A CANADIAN PERSPECTIVE

May 1, 2008, 00:00
10.1016/S1098-3015(10)70811-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)70811-1/fulltext
Title : PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS)-A CANADIAN PERSPECTIVE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70811-1&doi=10.1016/S1098-3015(10)70811-1
First page :
Section Title :
Open access? : No
Section Order : 561
Categories :
Tags :
Regions :
ViH Article Tags :